Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a…
Casey FrushourFebruary 28, 2022
Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through…
Casey FrushourFebruary 3, 2022
Fifth Eye™, a provider of intuitive real-time clinical analytics, today announced the FDA provided clearance…
Casey FrushourJanuary 31, 2022
EQRx, Inc. (Nasdaq: EQRX) a new type of pharmaceutical company committed to developing and delivering…
Casey FrushourJanuary 18, 2022
EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company committed to developing and delivering…
Casey FrushourJanuary 10, 2022
